Matthew K. Fust - Director at Ultragenyx Pharmaceutical Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RARE on Nasdaq
All Insider Reports
All Insider Reports

Matthew K. Fust - trading volume in the past year for Ultragenyx Pharmaceutical Inc.

Holdings reported by Matthew K. Fust for Ultragenyx Pharmaceutical Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20.2K $909K $45.00 Jun 18, 2024 Direct
Stock Option (Right to Buy) 9.9K Jun 18, 2024 Direct Common Stock

Transactions reported by Matthew K. Fust for Ultragenyx Pharmaceutical Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.